Associations of Serum testosterone and sex hormone-binding globulin with incident Arrhythmias in men from UK Biobank.
Arrhythmias
Atrial fibrillation/flutter
Sex hormone-binding globulin
Testosterone
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
04 Sep 2023
04 Sep 2023
Historique:
received:
12
04
2023
revised:
29
08
2023
accepted:
31
08
2023
medline:
4
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
aheadofprint
Résumé
Sex hormones have been identified as cardiovascular risk factors, while the relationship between sex hormones and the risk of arrhythmias in men has not yet been well studied in the prospective cohort study. To analyze associations of serum testosterone, sex hormone-binding globulin (SHBG) concentrations and calculated free testosterone (cFT) with arrhythmias in men. Sex hormones were measured at baseline from UK Biobank. Main outcomes were incidence of atrial fibrillation/flutter (AF), ventricular arrhythmia (VA), bradyarrhythmia (BA). Of 173 498 men (aged 37 to 73 years, followed for 11 years), 11 368 had incident AF, 1 646 had incident VA, and 4 788 had incident BA. Compared with the third quartiles, the lowest category of serum testosterone was associated with increased risks of AF (HR 1.06, 95% CI 1.00-1.12) and BA (HR 1.11, 95% CI 1.02-1.20) after multivariable adjustment, but no VA. Likewise, similar associations were found between cFT values and AF and BA events. Furthermore, higher levels of cFT were associated with increased risks of AF (HR 1.07, 95% CI 1.02-1.13) and VA (HR 1.18, 95% CI 1.01-1.37). Higher SHBG concentrations were associated with increased risks of AF (HR 1.44, 95% CI 1.34-1.54), VA (HR 1.27, 95% CI 1.07-1.52), and BA (HR 1.17, 95% CI 1.05-1.29). Lower levels of testosterone and cFT were associated with increased risk of AF and BA. Higher cFT levels were associated with increased risk of AF and VA. Higher SHBG levels were associated with increased risk of AF, VA, and BA.
Identifiants
pubmed: 37665960
pii: 7259838
doi: 10.1210/clinem/dgad526
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.